| Fund ID | 805-6639356856 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 85% |
| Fund | Type | Gross assets |
|---|---|---|
| Hsq Gemini SPV, LP | Other Private | $5.2M |
Hamilton Square Biotech Partners, LP reports $24.1 million in gross assets, among the top 66% of private funds by size.
The stated minimum investment is $1 million.
Hamilton Square Biotech Partners, LP is managed by Hamilton Square Partners Management, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.